Peer Reviewed
Feature Article Rheumatology and inflammatory pain
Update on spondyloarthritis
Abstract
Differentiating spondyloarthritides from more common mechanical back disorders is the major challenge in general practice.
Key Points
- Spondyloarthritis occurs in 2 to 3% of the population and can cause significant long term disability.
- Early diagnosis of spondyloarthritis is critical in the era of effective biological therapies.
- A detailed but focused history is essential in identifying early spondyloarthritis, when examination findings and radiographs may be normal.
- Traditional disease modifying antirheumatic drugs (DMARDs) are less effective in spondyloarthritis than in rheumatoid arthritis.
- Tumour necrosis factor (TNF) inhibitors have revolutionised the management of spondyloarthritis.
Get full access
Buy this article
Single article purchases are temporarily unavailable due to site maintenance.
If you would like to purchase an article during this time, please email us at [email protected] with the article details and we'll assist you directly. We'll also let you know when online purchasing is available again.
Thank you for your patience and understanding.
Already a subscriber? Login here.